Juniper Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JNP and buy or sell other stocks, ETFs, and their options commission-free!About JNP
Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets.
CEOJohn R. Chiminski
CEOJohn R. Chiminski
Employees—
Employees—
HeadquartersSomerset, New Jersey
HeadquartersSomerset, New Jersey
Founded1986
Founded1986
Employees—
Employees—
JNP Key Statistics
Market cap127.71M
Market cap127.71M
Price-Earnings ratio-115.00
Price-Earnings ratio-115.00
Dividend yield—
Dividend yield—
Average volume81.86K
Average volume81.86K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.25
52 Week high$13.25
52 Week low$4.30
52 Week low$4.30
Stock Snapshot
The current Juniper Pharmaceuticals(JNP) stock price is $11.48, with a market capitalization of 127.71M. The stock trades at a price-to-earnings (P/E) ratio of -115.00.
On 2025-11-25, Juniper Pharmaceuticals(JNP) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Juniper Pharmaceuticals(JNP) stock has reached 0, versus its average volume of 81.86K.
Over the past 52 weeks, Juniper Pharmaceuticals(JNP) stock has traded between a high of $13.25 and a low of $4.30.
Over the past 52 weeks, Juniper Pharmaceuticals(JNP) stock has traded between a high of $13.25 and a low of $4.30.